Biodesix (BDSX) Total Debt (2019 - 2026)

Biodesix (BDSX) has reported Total Debt for 8 consecutive years, with $46.5 million the latest figure, recorded in Q1 2026.

• Total Debt for Q1 2026 came in at $46.5 million, up 26.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $46.5 million (up 26.69% YoY), and the FY2025 annual result was $47.4 million, up 30.31% from the prior year.
• Total Debt was $46.5 million for Q1 2026 at Biodesix, down from $47.4 million in the prior quarter.
• Over five years, Total Debt peaked at $57.1 million in Q4 2023 and troughed at $14.2 million in Q3 2022.
• Average Total Debt over 5 years is $39.1 million, with a median of $39.2 million recorded in 2023.
• Year-over-year, Total Debt tumbled 67.13% in 2022 and jumped 212.42% in 2023.
• Over 5 years, Total Debt stood at $35.3 million in 2022, then surged by 61.5% to $57.1 million in 2023, then sank by 36.22% to $36.4 million in 2024, then soared by 30.31% to $47.4 million in 2025, then dropped by 2.02% to $46.5 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $46.5 million in Q1 2026, $47.4 million in Q4 2025, and $47.1 million in Q3 2025.